TOP-5 Analyst Target Prices as of January 15, 2026
Reading Time: 3 minutes
Rapid Micro Biosystems [US75340L1044] Lake Street confirms Buy rating with 8 USD (120 % price potential) The life sciences company has released preliminary revenue figures for the fourth quarter and the entire year 2025, signaling strong growth. For the fourth quarter, the microbiological testing automation specialist expects record revenue of approximately 11.3 million USD, representing an increase of about 37 % compared to the same quarter last year. For the entire year 2025, Rapid Micro anticipates revenue of around 33.6 million USD (consensus:...
Read this article now with a free account.
Your benefits:
- Every month, you can read 5 articles from the premium section for free.
- Monthly 2 trial issues of the Trader newspaper for free.
- Create a personal watchlist with an overview of news about your stock.
